# Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients

> **NCT00001311** · PHASE2 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 80 (—)

## Conditions studied

- Cataracts

## Interventions

- **DEVICE:** heparin-surface modified intraocular lens

## Key facts

- **NCT ID:** NCT00001311
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1992-04
- **Primary completion:** —
- **Final completion:** 2001-02
- **Target enrollment:** 80 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001311, "Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00001311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
